HURA 8-K 2026-11-06

TuHURA Biosciences, Inc./NV (HURA) 8-K dated 2026-11-06 — accession 0001193125-26-452007.

TuHURA Biosciences, Inc./NV (HURA) is a biotechnology company listed on US.

TuHURA Biosciences, Inc./NV filed a 8-K on 2026-11-06. Accession 0001193125-26-452007.

This 8-K covers: New debt obligation (Item 2.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported HURA revenue for 2025-12-31 was $0. Net income was -$30.1M. HURA currently screens at market cap $125.1M.

Not investment advice. The HURA SEC hub lists recent forms. The stock page is the research view.